Tumor	B-Cancer
angiogenesis	O
modulates	O
leukocyte	B-Cell
-	O
vessel	B-Multi-tissue_structure
wall	I-Multi-tissue_structure
interactions	O
in	O
vivo	O
by	O
reducing	O
endothelial	O
adhesion	O
molecule	O
expression	O
.	O

The	O
expression	O
of	O
endothelial	B-Cell
cell	I-Cell
(	O
EC	B-Cell
)	O
adhesion	O
molecules	O
involved	O
in	O
leukocyte	B-Cell
-	O
vessel	B-Multi-tissue_structure
wall	I-Multi-tissue_structure
interactions	O
is	O
suppressed	O
in	O
malignancies	B-Cancer
.	O

In	O
the	O
present	O
study	O
,	O
we	O
investigated	O
in	O
vivo	O
the	O
regulation	O
of	O
leukocyte	B-Cell
-	O
vessel	B-Multi-tissue_structure
wall	I-Multi-tissue_structure
interactions	O
by	O
the	O
presence	O
of	O
a	O
tumor	B-Cancer
.	O

By	O
means	O
of	O
intravital	O
microscopy	O
,	O
tumor	O
necrosis	O
factor	O
alpha	O
-	O
stimulated	O
leukocyte	B-Cell
-	O
vessel	B-Multi-tissue_structure
wall	I-Multi-tissue_structure
interactions	O
were	O
studied	O
in	O
ear	B-Tissue
skin	I-Tissue
microvessels	I-Tissue
of	O
nude	O
mice	O
bearing	O
small	O
human	O
LS174T	B-Cancer
colon	I-Cancer
carcinomas	I-Cancer
and	O
in	O
C57Bl	O
/	O
6	O
mice	O
bearing	O
murine	O
B16F10	B-Cancer
melanomas	I-Cancer
.	O

Leukocyte	B-Cell
-	O
vessel	B-Multi-tissue_structure
wall	I-Multi-tissue_structure
interactions	O
were	O
studied	O
both	O
within	O
and	O
outside	O
small	O
tumors	B-Cancer
growing	O
in	O
the	O
ear	B-Organ
,	O
and	O
in	O
ear	B-Tissue
microvessels	I-Tissue
of	O
mice	O
with	O
a	O
large	O
tumor	B-Cancer
growing	O
on	O
their	O
flank	B-Organism_subdivision
.	O

Tumor	B-Cancer
-	O
free	O
mice	O
were	O
used	O
as	O
controls	O
.	O

Compared	O
with	O
values	O
measured	O
at	O
the	O
edge	O
of	O
the	O
ear	B-Organ
and	O
in	O
the	O
contralateral	O
ear	B-Organ
,	O
leukocyte	B-Cell
adhesion	O
was	O
found	O
to	O
be	O
diminished	O
significantly	O
in	O
vessels	B-Multi-tissue_structure
inside	O
the	O
ear	B-Cancer
tumor	I-Cancer
in	O
both	O
mouse	O
models	O
.	O

This	O
reduction	O
disappeared	O
with	O
increasing	O
distance	O
from	O
the	O
tumor	B-Cancer
.	O

Surprisingly	O
,	O
the	O
level	O
of	O
leukocyte	B-Cell
adhesion	O
in	O
ear	B-Multi-tissue_structure
venules	I-Multi-tissue_structure
of	O
mice	O
with	O
a	O
large	O
flank	B-Cancer
tumor	I-Cancer
was	O
also	O
reduced	O
significantly	O
.	O

Leukocyte	B-Cell
rolling	O
,	O
i	O
.	O
e	O
.	O
,	O
the	O
step	O
preceding	O
adhesion	O
,	O
was	O
not	O
influenced	O
by	O
the	O
presence	O
of	O
a	O
tumor	B-Cancer
in	O
nude	O
mice	O
,	O
but	O
was	O
down	O
-	O
regulated	O
in	O
immune	O
-	O
competent	O
C57Bl	O
/	O
6	O
mice	O
.	O

Treatment	O
of	O
mice	O
bearing	O
a	O
small	O
ear	B-Cancer
tumor	I-Cancer
with	O
a	O
humanized	O
antivascular	O
endothelial	O
growth	O
factor	O
antibody	O
prevented	O
the	O
down	O
-	O
regulation	O
of	O
leukocyte	B-Cell
-	O
vessel	B-Multi-tissue_structure
wall	I-Multi-tissue_structure
interactions	O
inside	O
the	O
tumor	B-Multi-tissue_structure
vessels	I-Multi-tissue_structure
compared	O
with	O
the	O
nontreated	O
group	O
.	O

Fluorescence	O
-	O
activated	O
cell	B-Cell
sorter	O
analysis	O
showed	O
that	O
isolated	O
tumor	B-Cell
ECs	I-Cell
have	O
suppressed	O
levels	O
of	O
intercellular	O
adhesion	O
molecule	O
1	O
as	O
compared	O
with	O
ECs	B-Cell
from	O
normal	O
mouse	O
tissues	B-Tissue
.	O

In	O
cultured	O
b	B-Cell
.	I-Cell
END5	I-Cell
cells	I-Cell
the	O
tumor	O
necrosis	O
factor	O
alpha	O
-	O
induced	O
up	O
-	O
regulation	O
of	O
intercellular	O
adhesion	O
molecule	O
1	O
and	O
vascular	O
cell	O
adhesion	O
molecule	O
1	O
was	O
reduced	O
in	O
ECs	B-Cell
that	O
were	O
preincubated	O
with	O
basic	O
fibroblast	O
growth	O
factor	O
or	O
vascular	O
endothelial	O
growth	O
factor	O
.	O

The	O
current	O
results	O
may	O
have	O
an	O
impact	O
on	O
the	O
effectiveness	O
of	O
clinical	O
immunotherapeutic	O
treatment	O
protocols	O
,	O
because	O
immune	B-Cell
effector	I-Cell
cells	I-Cell
may	O
not	O
be	O
able	O
to	O
enter	O
tumor	B-Tissue
tissue	I-Tissue
.	O

